About Us
Overview
Leadership
Board of Directors
Join Our Team
Our Focus
Migraine
SMART Platform
Our Product
Atzumi™
News
Publications
Press Releases
Contact
STS101 (Dihydroergotamine Nasal Powder) Shows Long Duration Anti-Migraine Benefit on Baseline Photophobia,Phonophobia, and Nausea: Results From the Phase 3 Double-Blind, Randomized, Placebo-Controlled SUMMIT Study
About Us
Overview
Leadership
Board of Directors
Join Our Team
Our Focus
Migraine
SMART Platform
Our Product
Atzumi™
News
Publications
Press Releases
Contact